Logo
Search
Home
Frontiers in Medicine
Medical History
Weekly Readout
Acquisitions
Archive
Subscribe
Login
Sign Up
Logo
Biotech Readout
Biotech Readout

v

Weekly Readout

Genmab scores two cancer wins, CAR-T unravels AL amyloidosis, and more

Oct 9, 2026

•

24 min read

Genmab scores two cancer wins, CAR-T unravels AL amyloidosis, and more

Weekly Readout #25: Week ending October 9, 2026

Biotech Readout
Biotech Readout

Weekly Readout

EADV 2026

Oct 7, 2026

•

19 min read

EADV 2026

Breakthroughs from Europe's largest dermatological conference

Biotech Readout
Biotech Readout

Acquisitions

Shionogi to Acquire IntraBio

Oct 5, 2026

•

15 min read

Shionogi to Acquire IntraBio

How four professors teamed up with a serial entrepreneur to teach an old drug new tricks

Biotech Readout
Biotech Readout

Weekly Readout

EASD 2026

Oct 2, 2026

•

25 min read

EASD 2026

Breakthroughs & debates from Europe's largest diabetes conference

Biotech Readout
Biotech Readout

Weekly Readout

Pharma voices urgent concerns about degrading EU innovation, Viking maintains weight loss with less frequent dosing, and more

Sep 25, 2026

•

23 min read

Pharma voices urgent concerns about degrading EU innovation, Viking maintains weight loss with less frequent dosing, and more

Weekly Readout #24: Week ending September 25, 2026

Biotech Readout
Biotech Readout

Acquisitions

Telix to Merge with ITM Isotope

Sep 21, 2026

•

13 min read

Telix to Merge with ITM Isotope

Nuclear fusion between two radiopharmaceutical powerhouses

Biotech Readout
Biotech Readout

Weekly Readout

China publishes 5-year plan for biotech, Definium secures 2nd anxiety win, and more

Sep 18, 2026

•

11 min read

China publishes 5-year plan for biotech, Definium secures 2nd anxiety win, and more

Weekly Readout #23: Week ending September 18, 2026

Biotech Readout
Biotech Readout

Weekly Readout

WCLC 2026

Sep 16, 2026

•

22 min read

WCLC 2026

Breakthroughs from the world’s largest lung cancer conference

Biotech Readout
Biotech Readout

Weekly Readout

Roivant's respiratory win, Beam rewrites a gene, and more

Sep 11, 2026

•

20 min read

Roivant's respiratory win, Beam rewrites a gene, and more

Weekly Readout #22: Week ending September 11, 2026

Biotech Readout
Biotech Readout

Weekly Readout

RevMed's pancreatic cancer medicine posts early results in lung cancer, GSK enters mRNA vaccine space, and more

Sep 4, 2026

•

17 min read

RevMed's pancreatic cancer medicine posts early results in lung cancer, GSK enters mRNA vaccine space, and more

Weekly Readout #21: Week ending September 4, 2026

Biotech Readout
Biotech Readout

Weekly Readout

ESC 2026

Sep 1, 2026

•

23 min read

ESC 2026

Breakthroughs and debates from Europe's largest cardiology conference

Biotech Readout
Biotech Readout

Acquisitions

Eli Lilly to Acquire Merida

Aug 31, 2026

•

9 min read

Eli Lilly to Acquire Merida

Laying traps for antibody rebels

Biotech Readout
Biotech Readout

Frontiers in Medicine

Programming Medicines to Attack Cancer

Aug 29, 2026

•

26 min read

Programming Medicines to Attack Cancer

How a 75-year collaboration between tech & biotech birthed the precision oncology revolution

Biotech Readout
Biotech Readout

Weekly Readout

RevMed's pancreatic cancer medicine approved, Eli Lilly's GLP1-GIP tirzepatide prevents heart attack & stroke, and more

Aug 28, 2026

•

19 min read

RevMed's pancreatic cancer medicine approved, Eli Lilly's GLP1-GIP tirzepatide prevents heart attack & stroke, and more

Weekly Readout #20: Week ending August 28, 2026

Biotech Readout
Biotech Readout

Weekly Readout

Moderna's cancer vaccine makes a splash, Amylyx returns with anti-GLP1, and more

Aug 21, 2026

•

17 min read

Moderna's cancer vaccine makes a splash, Amylyx returns with anti-GLP1, and more

Weekly Readout #19: Week ending August 20, 2026

Biotech Readout
Biotech Readout

Acquisitions

BioMarin to Acquire Alesta

Aug 18, 2026

•

11 min read

BioMarin to Acquire Alesta

Rare disease maven bets on a next generation bone-forming medicine

Biotech Readout
Biotech Readout

Weekly Readout

Biotechs post wins in menopause hot flashes, anxiety disorder, polycythemia vera, and more

Aug 14, 2026

•

9 min read

Biotechs post wins in menopause hot flashes, anxiety disorder, polycythemia vera, and more

Weekly Readout #18: Week ending August 14, 2026

Biotech Readout
Biotech Readout

Acquisitions

Jazz to Acquire Actio

Aug 10, 2026

•

9 min read

Jazz to Acquire Actio

How David Goldstein's precision neuroscience thesis hit escape velocity

Biotech Readout
Biotech Readout

Acquisitions

AstraZeneca-BMS Merger Cancelled

Aug 8, 2026

•

9 min read

AstraZeneca-BMS Merger Cancelled

Exploring the Pax Pharmaceutica that never arrived

Biotech Readout
Biotech Readout

Weekly Readout

Surprise approvals of Replimune's RP1 & Moderna's flu vaccine, orexin unlocks narcolepsy, and more

Aug 7, 2026

•

11 min read

Surprise approvals of Replimune's RP1 & Moderna's flu vaccine, orexin unlocks narcolepsy, and more

Weekly Readout #17: Week ending August 7, 2026

Biotech Readout
Biotech Readout

Medical History

Hepatitis C, Part 2

Aug 1, 2026

•

25 min read

Hepatitis C, Part 2

How Pharmasset teamed up with Gilead and bested big pharma in the race for a cure

Biotech Readout
Biotech Readout

Weekly Readout

Obesity drug treats alcoholism, a China-originated drug pursues $30 billion market, and more

Jul 31, 2026

•

12 min read

Obesity drug treats alcoholism, a China-originated drug pursues $30 billion market, and more

Weekly Readout #16: Week ending July 31, 2026

Biotech Readout
Biotech Readout

Acquisitions

Argenx to Acquire Forte Biosciences

Jul 27, 2026

•

10 min read

Argenx to Acquire Forte Biosciences

How Paul Wagner's pivot from microbiome medicines to CD122 for celiac and vitiligo paid off

Biotech Readout
Biotech Readout

Weekly Readout

GSK-Nuvalent buyout bears fruit, diabetic obesity drug raises the bar, and more

Jul 24, 2026

•

12 min read

GSK-Nuvalent buyout bears fruit, diabetic obesity drug raises the bar, and more

Weekly Readout #15: Week ending July 24, 2026

Biotech Readout
Biotech Readout

Medical History

Hepatitis C, Part 1

Jul 18, 2026

•

24 min read

Hepatitis C, Part 1

How Schering-Plough, Roche, Merck, Vertex, and Janssen turned the tide from a public health epidemic to an 80% cure rate

Biotech Readout
Biotech Readout
Load more

Biotech Readout

Highlighting biotech innovation every week.

© 2026 Biotech Readout.
beehiivPowered by beehiiv